Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 2

Status

Unknown 3Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Lymphoma, B-Cell 1Lymphoma 1Hepatitis B 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Tenofovir × Clear all
NCT04539119 2020-09-04

Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA

Ruijin Hospital

Phase 3 Unknown
120 enrolled
Lymphoid

Lymphoma, B-Cell

NCT04392700 2020-05-19

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection

Sun Yat-sen University

Phase 3 Unknown
706 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown
184 enrolled
Lymphoid

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡